Optineurin (INT) Blocking Peptide Reference: 300002-1 Peptide Sequence: human optineurin amino acids 115-130 (KGKSERSSEDPTDDSR) · To be used in conjunction with Cayman’s optineurin (INT) polyclonal antibody (Catalog No. 100002) to block protein-antibody complex formation during analysis of optineurin.
HIF-1α (C-Term) Blocking Peptide Reference: 300003-1 Peptide Sequence: HIF-1α protein amino acids (SRNLLQGEELLRALDQVN) · To be used in conjunction with Cayman’s HIF-1α Polyclonal Antibody (Item No. 10006421) to block protein-antibody complex formation during immunochemical analysis of HIF-1α.
CD36 Blocking Peptide Reference: 300011-1 Peptide Sequence: human CD36 sequence amino acids 98-114 (AKENVTQDAEDNTVSF) · To be used in conjunction with Cayman’s CD36 polyclonal antibody (Catalog No. 100011) to block protein-antibody complex formation during immunochemical analysis of CD36.
Prostaglandin E Synthase-2 (microsomal) Blocking Peptide Reference: 300012-1 Peptide Sequence: amino acids 221-235 (VYGGKEARTEEMKWR) · To be used in conjunction with Cayman’s mPGE synthase-2 polyclonal antibody (Catalog No. 160145) to block protein-antibody complex formation during analysis for microsomal PGE synthase-2.
β-Catenin Blocking Peptide Reference: 300013-1 Peptide Sequence: human β-catenin amino acids 43-62 (APSLSGKGNPEEEDVDTSQV) · To be used in conjunction with Cayman’s β-catenin polyclonal antibody (Catalog No. 100029) to block protein-antibody complex formation during analysis for β-catenin.
Monoacylglycerol Lipase Blocking Peptide Reference: 300014-1 Peptide Sequence: human monoacylglycerol lipase blocking peptide amino acids 1-14 (MPEESSPRRTPQSI) · To be used in conjunction with Cayman’s Monoacylglycerol Lipase Polyclonal Antibody (Item No. 100035) to block protein-antibody complex formation during analysis for monoacylglycerol lipase.
CB2 Receptor Blocking Peptide Reference: 301550-200 Peptide Sequence: human CB2 receptor sequence amino acids 20-33 (NPMKDYMILSGPQK)(6724) · To be used in conjunction with Cayman’s CB2 receptor polyclonal antibody (Catalog No. 101550) to block protein-antibody complex formation during analysis for the CB2 receptor. · The CB2 receptor is localized predominantly in peripheral tissues, including the spleen and hemopoietic cells.(6724)
Fatty Acid Amide Hydrolase Blocking Peptide Reference: 301600-1 Peptide Sequence: rat FAAH amino acids sequence 561-579 (CLRFMREVEQLMTPQKQPS)(9140) · To be used in conjunction with Cayman’s FAAH polyclonal antibody (Catalog No. 101600) to block protein-antibody complex formation during analysis for FAAH.
DP1 Receptor Blocking Peptide Reference: 301640-1 To be used in conjunction with Cayman’s DP1 Receptor Polyclonal Antibody (Catalog No. 101640) to block protein-antibody complex formation during immunochemical analysis of the DP1 receptor.
PPARγ Blocking Peptide Reference: 301700-1 Peptide Sequence: human PPARγ1 amino acids 82-101 (PASPPYYSEKTQLYNKPHEE; amino acids 110-129 of PPARγ2) · To be used in conjunction with Cayman’s PPARγ polyclonal antibody (Catalog No. 101700) to block protein-antibody complex formation during analysis for PPARγ.
PPARα Blocking Peptide Reference: 301710-1 Peptide sequence: human PPARα amino acids 22-36 (PLSEEFLQEMGNIQE)(6160) · To be used in conjunction with Cayman’s PPARα polyclonal antibody (Item No. 101710) to block protein-antibody complex formation during analysis for PPARα.
EP1 Receptor Blocking Peptide Reference: 301740-1 Peptide Sequence: human EP1 receptor C-terminal amino acids 380-402 (GLTPSAWEASSLRSSRHSGLSHF)(3176) · To be used in conjunction with Cayman’s EP1 receptor polyclonal antibody (Catalog No. 101740) to block protein-antibody complex formation during analysis for the EP1 receptor.